Small caps fell across the broader market, with the AIM 100 index falling 2% to 4,089 and the FTSE 100 blue chips losing 0.8% and 1.5%, respectively.
Small caps fell across the broader market, with the AIM 100 index falling 2% to 4,089 and the FTSE 100 blue chips losing 0.8% and 1.5%, respectively.
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, provides a trading update which reflects lower than expected revenue,
Maiden US Laboratory FoodPrint® installation,
Test shows high diagnostic accuracy (specificity and sensitivity)
Change of preliminary results date and investor presentation and update to CD4 sale
Completion of Sale of the CD4 Business
Omega Diagnostics Group PLC, (AIM: ODX). announced that it has selected a preferred bidder for its CD4 business after having made an announcement nearly two months back.
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces the results of its Open Offer.
Placing of 50,000,000 New Ordinary Shares and Warrants
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health (CD4 and COVID-19) products, provides the following trading update for the year ended
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health (CD4 and COVID-19) products, today announces the results of its Open Offer.